LobbyingAmalgent Therapeutics lobbying by quarter
Amalgent Therapeutics's latest lobbying report covers Q2 2026, at $10K. Its first report covers Q1 2026; the issues it reports most are Defense.
Amalgent Therapeutics
- Latest quarter
- $10K
- Q2 2026 · 1 reports
- Last 12 months
- $20K
- Last 2 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $10K | 1 |
| Q2 2026 | $10K | 1 |
Policy issues the reports name
- Defense2 reports
A report that names several issues counts once for each.
Who was lobbied
- Defense, Dept of (DOD)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Prospering Solutions, LLC Fka John C. Snyder III | $20K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Prospering Solutions, LLC Fka John C. Snyder III | $10K |
| 07/20for Q1 | Prospering Solutions, LLC Fka John C. Snyder III | $10K |
| 04/22for Q1 | Prospering Solutions, LLC Fka John C. Snyder III | Under $5,000 |